Advantages of Using Same Species Enzyme for Replacement Therapy in a Feline Model of Mucopolysaccharidosis Type VI
Open Access
- 1 December 1999
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (51) , 36335-36343
- https://doi.org/10.1074/jbc.274.51.36335
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.Journal of Clinical Investigation, 1997
- Feline Mucopolysaccharidosis Type VIJournal of Biological Chemistry, 1996
- Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.Journal of Clinical Investigation, 1996
- Immunochemical Characterization of Feline and Human N-Acetylgalactosamine 4-SulfataseBiochemical Medicine and Metabolic Biology, 1994
- Feline arylsulfatase B (ARSB): Isolation and expression of the cDNA, comparison with human ARSB, and gene localization to feline chromosome A1Genomics, 1992
- Effect of ammonium chloride on subcellular distribution of lysosomal enzymes in human fibroblastsExperimental Cell Research, 1988
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Bone-Marrow Transplantation in the Maroteaux–Lamy Syndrome (Mucopolysaccharidosis Type VI)New England Journal of Medicine, 1984
- A simple spectrophotometric method for estimating glycosaminoglycan concentrationsAnalytical Biochemistry, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970